Ropes & Gray-Advised Neurogastrx Closes $60M Series B

By Emma Whitford (August 26, 2021, 12:21 PM EDT) -- Gastrointestinal disorder-focused pharmaceutical company Neurogastrx, advised by Ropes & Gray LLP, said Thursday that it has raised $60 million in a crossover funding round led by health care investment firm Vivo Capital....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!